NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. USO
2. DHR
3. NVDA
4. SPY
5. AMD
6. NOW
7. GM
8. SMCI
9. GOOGL
10. TSLA

Go back to NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets
(NASDAQ: ELAB) Delayed: 1.02 -0.03 (2.86%)
Previous Close $1.05    52 Week High $ 
Open $1.02    52 Week Low $ 
Day High $1.05    P/E N/A 
Day Low $1.01    EPS $ 
Volume 1,502,036       

(NASDAQ: ELAB) Delayed: 1.02 -0.03 (2.86%)
Previous Close $1.05    52 Week High $ 
Open $1.02    52 Week Low $ 
Day High $1.05    P/E N/A 
Day Low $1.01    EPS $ 
Volume 1,502,036